A striking phenomenon is that some of those patients who have rare multiple combinations of gene changes, including both PCSK9 GOF and LDLR LOF, will have an LDL level between that of FH and normal cholesterol. This evidence concerns the gene LDLR and familial hyperaldosteronism.